To study conformational transitions at the muscle nicotinic acetylcholine (ACh) receptor (nAChR), a rhodamine fluorophore was tethered to a Cys side chain introduced at the ␤19 position in the M2 region of the nAChR expressed in Xenopus oocytes. This procedure led to only minor changes in receptor function. During agonist application, fluorescence increased by (⌬F͞F) Ϸ10%, and the emission peak shifted to lower wavelengths, indicating a more hydrophobic environment for the fluorophore. The dose-response relations for ⌬F agreed well with those for epibatidine-induced currents, but were shifted Ϸ100-fold to the left of those for ACh-induced currents. Because (i) epibatidine binds more tightly to the ␣␥-binding site than to the ␣␦ site and (ii) ACh binds with reverse-site selectivity, these data suggest that ⌬F monitors an event linked to binding specifically at the ␣␦-subunit interface. In experiments with flash-applied agonists, the earliest detectable ⌬F occurs within milliseconds, i.e., during activation. T he muscle nicotinic acetylcholine receptor (nAChR) is a well studied member of the Cys-loop family of neurotransmittergated ion channels. A 4.6-Å structure (1) shows five Ϸ160-Å-long rod-shaped subunits surrounding a central channel. From the extracellular side the subunits have a counterclockwise order of ␣␥␣␦␤ (2, 3). Each subunit has a large extracellular Nterminal or ligand-binding domain followed by four transmembrane regions, M1-M4 (4). The structure of the extracellular ligand-binding sites, at the ␣␥ and ␣␦ interfaces, resembles that of a homologous molluscan ACh-binding protein (3). Numerous biochemical and electrophysiological experiments indicate that M2 lines the channel (5).
T he muscle nicotinic acetylcholine receptor (nAChR) is a well studied member of the Cys-loop family of neurotransmittergated ion channels. A 4.6-Å structure (1) shows five Ϸ160-Å-long rod-shaped subunits surrounding a central channel. From the extracellular side the subunits have a counterclockwise order of ␣␥␣␦␤ (2, 3) . Each subunit has a large extracellular Nterminal or ligand-binding domain followed by four transmembrane regions, M1-M4 (4). The structure of the extracellular ligand-binding sites, at the ␣␥ and ␣␦ interfaces, resembles that of a homologous molluscan ACh-binding protein (3) . Numerous biochemical and electrophysiological experiments indicate that M2 lines the channel (5) .
The nAChR exists in at least four distinct, interconvertible conformational states: resting, open, fast-onset-desensitized, and slow-onset-desensitized (6) . The open and the fast-onsetdesensitized states presumably have moderate affinity for ACh, are metastable (on millisecond time scales), and are present in low concentrations at equilibrium. The supralinear doseresponse relation (Hill coefficient Ͼ1) suggests that the open state of the channel is much more likely to be associated with the presence of two bound agonist molecules than with a single bound agonist (7) . In the prevailing kinetic scheme, receptors in the resting state bind two agonist molecules, isomerize to the open state, and in the continued presence of agonist, desensitize.
After removal of agonist, the agonist-receptor complex dissociates and the channel closes within milliseconds; but desensitized receptors isomerize more slowly to the resting state (tens of milliseconds to hundreds of seconds). Thermodynamic considerations suggest that the resting state has low affinity for agonist, whereas the slow-onset-desensitized state is the most stable state in the presence of agonist because of its high affinity.
Kinetic analyses of single-channel and macroscopic function suggests that in the resting state, the affinity of ACh for the two sites differs by a factor of 30 (8) . Experiments with partially assembled ␣␥ and ␣␦ dimers or with fully assembled, pentameric ␥-less or ␦-less receptors show that the ␣␦ site has the higher affinity for ACh or carbamylcholine (9) (10) (11) . Interestingly, epibatidine binds with 75-fold higher affinity to the ␣␥ site (10) .
To learn more about the changes in state and͞or conformation, one requires a structural probe that reveals changes in real time as receptors proceed through electrophysiologically defined states. Covalently bound fluorescent probes have proven useful for this purpose at other ion channels and, recently, for ␥-aminobutyric acid type C receptors as well (12) . We have now covalently modified a Cys at the extracellular end of M2 with a thiol-reactive fluorophore, and we report fluorescence changes during receptor activation and desensitization. This report begins the analysis of these changes.
Materials and Methods
Reagents and Solutions. The fluorescent dye sulforhodamine methanethiosulfonate (MTSR) and the blocking reagent Na (2-sulfonatoethyl) methanethiosulfonate were purchased from Toronto Research Chemicals. The photoisomerizable agonist 3,3Ј-bis-[␣-(trimethylammonium)methyl]azobenzene (Bis-Q) was prepared (13) . Other reagents, including (Ϯ)-epibatidine, were purchased from Sigma. The full-Na recording solution, ND-96, contained 96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , and 5 mM Hepes (pH 7.4). For low-Na recording solution, NaCl was partially replaced with equimolar N-methyl-D-glucamine. The incubation solution contained ND-96 solution plus 1.8 mM CaCl 2 , 0.6 mM theophylline, 2.5 mM pyruvic acid, 50 g͞ml gentamycin, and 5% horse serum.
Molecular Biology. A pSP64T construct encoding the nAChR ␤-subunit with an A272C mutation (the ␤M2 19Ј position) was obtained from A. Karlin. A 714-bp BstEII͞BspEI fragment was transferred to the corresponding site of a pAMV construct encoding the wild-type ␤-subunit. Capped mRNA for the embryonic mouse muscle nAChR subunits were prepared by in vitro runoff transcription (Ambion mMagic mMessage).
Oocyte Preparation and mRNA Injection. Stage VI oocytes of Xenopus laevis were harvested (14) and injected with 30 ng of mRNA at a subunit ratio 2:1:1:1 ␣:␤:␥:␦. To achieve the high levels of expression required for detection of the fluorescent label over the background fluorescence (caused by oocyte autofluorescence and by nonspecific binding of dye), oocytes were incubated for 6-8 days at 18°C. Fluorescent Labeling. Oocytes were rinsed and then reacted with 10 mM Na (2-sulfonatoethyl) methanethiosulfonate for 90 s to block endogenous surface sulfhydryl groups, terminated by 5 mg͞ml BSA. Cys at the ␤M2 19Ј position does not react with Na (2-sulfonatoethyl) methanethiosulfonate (15) . After a wash, the oocytes were labeled with 5 M MTSR plus 100 M ACh for 45 s, terminated by a 5 mg͞ml BSA solution. BSA, Na (2-sulfonatoethyl) methanethiosulfonate, and MTSR reagents were made up in ND-96 just before use, and all steps were performed on ice. Labeled oocytes were stored in incubating solution at 4°C for up to 72 h after labeling.
Spectral Analysis. Emission spectra from oocytes were obtained with a spectrograph and intensified charge-coupled device camera combination as described (16) . Excitation filter was 535DF35, dichroic mirror was 565DRLP; no emission filter was used. Emission spectra of free MTSR dissolved in ethanol and ND98 were obtained with an SLM-Aminco fluorometer (SLM Instruments, Urbana, IL).
Simultaneous Recording of Current and Fluorescence Intensity. In the inverted fluorescence microscope fitted with a high-Q tetramethylrhodamine isothiocyanate filter set (Chroma Technology, Rockingham, VT), a 40ϫ objective lens (N.A. 0.7, working distance 510 m), and a photomultiplier tube (R928P, Photon Technology International, Lawrenceville, NJ) (17), a black block Ϸ0.4 mm high bearing a vertical slit 0.75 mm wide exposed the animal pole of the oocyte to both the perfusion solution and the beam from the 100-W Hg lamp (17) . This arrangement allowed efficient perfusion of nearly the entire oocyte surface, including the optically monitored area at the top of the slit. Two-electrode voltage clamp procedures were used (GeneClamp 500, Axon Instruments). The holding potential was Ϫ80 mV (ACh recordings) or Ϫ60 mV (epibatidine recordings). With ND-96, the average 1-M ACh response of a batch of oocytes expressing ␤A19ЈC nAChR (␤19ЈC) was 200-1,000 nA before MTSR labeling, suggesting extrapolated responses of 40-200 A to saturating doses of ACh. These currents cannot be measured accurately with our circuits; therefore, where indicated, responses were measured in low-Na recording solution.
Current and fluorescence traces were acquired at 40 Hz with an Axon Digidata interface and pCLAMP8. The fluorescence signal was filtered at 5 Hz by an eight-pole low-pass filter, then subjected to further digital filtering (1-2 Hz eight-pole Bessel) and baseline adjustment where appropriate. Waveforms were fitted to single or double exponentials with routines in ORIGIN 7 and CLAMPFIT 8. Dose-response relationships were fit to the Hill equation by using ORIGIN 7. All current and fluorescent measurements are presented as mean Ϯ SE. 
Results

Fluorescent Labeling of ␤A19C nAChR.
It is convenient to renumber the amino acid sequence of M2 segments lining the nAChR channel, so that 1Ј is near the cytoplasm and 20Ј is near the extracellular solution (18) . Ala-272 at the 19Ј position of ␤M2 was mutated to Cys to allow modification with MTSR, a thiolreactive fluorophore. After labeling, ␤19ЈC-injected oocytes were twice as fluorescent as uninjected or WT nAChR-injected oocytes (data not shown). ACh dose-response relations were measured for WT-expressing oocytes and for labeled and unlabeled ␤19ЈC-expressing oocytes and showed no major changes; WT, ␤19ЈC, and MTSR-modified ␤19ЈC had EC 50 s of 24 Ϯ 1, 35 Ϯ 1, and 43 Ϯ 4 M, respectively, and Hill coefficients of 1.44 Ϯ 0.04, 1.24 Ϯ 0.06, and 1.36 Ϯ 0.14, respectively (Fig. 1A) . However, MTSR labeling did subtly alter ␤19ЈC receptor function. Measurements of the response at [ACh] Յ 3 M before and after labeling (Fig. 1C ) indicated that whereas MTSR had little or no effect on the WT response (decrease of 15 Ϯ 15%, n ϭ 4), it enhanced the ␤19ЈC current response by 528 Ϯ 107% (n ϭ 3); thus, the responses to 1 and 3 M ACh were greater than the values predicted by fits of the Hill equation (Fig. 2D) . The response waveforms before and after modification also show that MTSR modification increased the rate of ␤19ЈC desensitization.
Further indications of altered receptor function come from the dose-response relation for epibatidine. Whereas WT and ␤19ЈC had EC 50 s of 13.1 Ϯ 1.1 M and 14.8 Ϯ 1.8 M epibatidine, respectively, the EC 50 for MTSR-labeled ␤19ЈC was one order of magnitude lower, 1.11 Ϯ 0.11 M (Fig. 1B) . The Hill coefficients showed only slight changes; WT-, ␤19ЈC-, and MTSR-labeled ␤19ЈC had Hill coefficients of 0.93 Ϯ 0.05, 1.10 Ϯ 0.11, and 1.22 Ϯ 0.12, respectively. These changes in nAChR function may occur because MTSR labeling increased the affinity of the ␣␦ site for agonist (see below).
ACh-Mediated Changes in Fluorescence Intensity. Simultaneous measurements of current and fluorescence intensity indicated (Fig. 2 A) that agonist application resulted in increased fluorescence (⌬F). Such a ⌬F never occurred with control oocytes. At low doses of ACh (Յ10 M), ⌬F was biphasic. In bath application experiments, the faster phase (⌬F f ) was indistinguishable from the time course of the current responses, which in turn cannot be distinguished from the time course of solution change near the oocyte. The slower phase (⌬F s ) was similar to that of desensitization (Fig. 2 A; analyzed in Fig. 5 below) . At [ACh] Ն 10 M, ⌬F reached its maximum magnitude (average ⌬F͞F Ϸ10%) and consisted of a single component that increased with the same time course as the rise of the current, with no further change in fluorescence intensity during desensitization (Fig. 2 B  and C) . To measure the dose-response relation of ⌬F f (Fig. 2D) , fluorescence intensity was determined at peak current. Although ⌬F f was simultaneous with the rising phase of the current response, it clearly did not correlate with activation; with ACh, the EC 50 for ⌬F f (266 Ϯ 43 nM, Hill coefficient ϭ 0.53 Ϯ 0.04) was two orders of magnitude lower than the EC 50 for the current response (43 Ϯ 4 M). Thus, ACh-mediated ⌬F f corresponds to a transition that reaches full occupancy at [ACh] much less than the EC 50 for activation.
Photoisomerization of cis-Bis-Q Reveals That ⌬F Is Complete Within 20 ms. We used Ϸ1-ms light flashes to jump the concentration (Fig.  3) of the photoisomerizable agonist trans-Bis-Q (19) . The flashinduced ⌬I was fitted by a single exponential with ϭ 5.5 and 5.3 ms for ␤19ЈC and WT, respectively. As perfusion continued with the inactive cis-Bis-Q isomer, ⌬I decayed ( ϭ 2.6-2.9 s) due to washout and diffusion of trans-Bis-Q as well as desensitization (data not shown). A ⌬F (1.8%) was seen for ␤19ЈC (Fig. 3) but not WT-expressing oocytes (data not shown). The absolute flash-induced ⌬F was comparable with ⌬F for bath-applied trans-Bis-Q; but background fluorescence was larger, because we recorded from the vegetal pole, which is more resistant to light flashes but is also approximately five times more autofluorescent. Thus, a component of ⌬F is complete within 20 ms after an agonist concentration jump, one to two orders of magnitude faster than Bis-Q-mediated desensitization.
Epibatidine-Mediated ⌬Ff Corresponds to a Step Tightly Coupled to
Channel Activation. Compared with ACh and carbamylcholine, epibatidine activates muscle nAChR with unique site-selectivity (10) . We tested the dose-response relation of ⌬F f by using epibatidine as the agonist. To compare the current and fluorescence responses to the two agonists, individual, MTSR-labeled, ␤19ЈC-injected oocytes were perfused with a saturating dose of ACh and, after allowing for recovery, a saturating dose of epibatidine (Fig. 4A) . Epibatidine was a partial agonist; 30 M epibatidine (a dose 27 times greater than EC 50 ) elicited currents Fig. 1 ) and for ⌬F f, the magnitude of the fluorescence shift at the time of the peak ACh-induced current (n ϭ 3-12 responses per dose). The dose-response relation for ⌬F f was normalized to the value for full ⌬F response of a saturating dose (Ն10 M ACh).
[Na] was 20% of normal. from MTSR-labeled ␤19ЈC that were 0.23 Ϯ 0.02 (n ϭ 4) of that elicited by 1,000 M ACh (a dose 23 times greater than EC 50 ). Saturating doses of both agonists, however, elicited similar increases in fluorescence intensity; the magnitude of the epibatidine ⌬F was 1.08 Ϯ 0.24 (n ϭ 3) that of the ACh ⌬F, suggesting that the two agonists mediate similar changes in the fluorophore environment. Interestingly, whereas ACh elicited a biphasic ⌬F only at low doses, epibatidine produced a biphasic ⌬F at all doses tested. At saturating doses of agonist, the epibatidine ⌬F f was only 0.63 Ϯ 0.10 (n ϭ 3) of the ACh ⌬F f . A more striking difference was in the dose-response relation for ⌬F f (Fig. 4C) . Whereas with ACh the EC 50 for ⌬F f and for current activation differed by two orders of magnitude, with epibatidine, the EC 50 for ⌬F f and for current activation were indistinguishable at 0.99 Ϯ 0.15 M and 1.11 Ϯ 0.11 M, respectively. The Hill coefficient for ⌬F f was 1.13 Ϯ 0.16.
The Slower Phase of the Fluorescence Shift Correlates with Desensi-
tization. Time constants determined by fitting the desensitization component of the current waveform with a single exponential function were compared with the slower of the two time constants derived from fitting the entire, matching ⌬F waveform with a double exponential function. Despite considerable variability in desensitization time constants, for both ACh and epibatidine ( Fig. 5 A and B) , there is good agreement between the time constant for ⌬F s and for current desensitization over a Ͼ20-fold range (3-70 s).
Recovery of Fluorescence Baseline Is Faster than Recovery from the
Desensitized State. Upon removal of agonist the current decays faster than the fluorescence signal (Fig. 6A) , suggesting that at least one short-lived (several seconds) desensitized state is (C) Dose-response relations and fits to the Hill equation for epibatidine-induced current (determined as described in Fig. 1 ) and ⌬F f (n ϭ 4 -8).
[Na] was 50% of normal. f luorescent. To determine whether exit from the highfluorescence state correlates with exit from all physiologically defined desensitized states, recovery from desensitization induced by a prolonged (5-min) application of 10 M ACh was monitored by means of brief (1-s) pulses of 1 M ACh at 28-s intervals (Fig. 6B) . The recovery of the fluorescence signal (F, Fig. 6B ) is measured only approximately; but fits to a singleexponential function show a time constant several fold less than that for the recovery of the current (E, 51 Ϯ 7 vs. 248 Ϯ 17 s, respectively, n ϭ 5). These data indicate that, upon removal of agonist, MTSR-labeled ␤19ЈC also transiently occupies at least one long-lived (several minutes) desensitized state that does not show high fluorescence.
⌬F Monitors an Increase in the Hydrophobicity of the Fluorophore's Local Environment. As solvent hydrophobicity increases, MTSR emission intensity increases and the spectrum becomes blueshifted ( Ethanol ϭ 574 nm; ND98 ϭ 584 nm). In the oocyte, a desensitizing dose of ACh also increased the emission intensity and blue-shifted the emission peak by Ϸ10 nm (Fig. 7A) . Therefore, ⌬F occurs because the fluorophore occupies a more hydrophobic environment in the desensitized state than in the resting state, rather than because a quencher moves away (however, we cannot rule out the occurrence of both mechanisms together). There were no spectral shifts with control oocytes (Fig. 7B) .
Discussion
In the standard kinetic scheme for nAChR activation, channel opening follows the sequential binding of agonist at the ␣␦ and ␣␥ sites. By using a fluorophore attached to the extracellular end of nAChR M2, we detected one of the several agonist-induced transitions. Which transition was detected?
A Scheme for the Observations. Fig. 8 shows a model that rationalizes our observations. In this scheme, a dagger ( †) indicates a high fluorescence state, and all † states are assumed to be equally fluorescent. Both ⌬F f and ⌬F s occur when the fluorophore senses a conformational change due to productive binding of agonist to the ␣␦ site. Because the ␣␦ site is the high-affinity site for ACh but the low-affinity site for epibatidine, these two agonists are predicted to induce ⌬F at different regions of the dose-response relation for agonist-induced currents.
This model accounts for many properties of the ⌬F response. Because ACh has 30 times higher affinity for the ␣␦ site (8), AR ␣␦ † is fully occupied at [ACh] much lower than required for fully occupying A 2 R O † . Assuming the MTSR labeling does not markedly change the site selectivity of ACh and epibatidine, this hypothesis explains how ACh EC 50 for ⌬F and for ⌬I differ by a factor of 160.
Epibatidine has reverse-site selectivity. Thus, epibatidine binding to the ␣␦ site occurs predominately during formation of A 2 R O † , explaining why the EC 50 for ⌬F and for ⌬I are indistinguishable with epibatidine.
What is the explanation for ⌬F s ? With ACh, ⌬F s appears only at agonist concentrations too low to saturate the ␣␦ site. Under these conditions, ⌬F s represents equilibration among the various comparably fluorescent R † states. More slowly, receptors enter the slow-onset-desensitized A 2 D † state(s), pulling the entire equilibrium to the right, and increasing the overall population of R † states with a time constant equal to that of desensitization. Thus, the time constants are equal for ⌬F s and current desensitization, not because the open and desensitized states differ in fluorescence, but because the desensitized state(s) is one of the fluorescent states and because desensitization is the rate-limiting step for the equilibration, seen at low agonist dose, of the various R † states. That flash-activation of trans-Bis-Q produces ⌬F within 20 ms, much faster than desensitization, argues decisively against a major role for even fast desensitization as the transition that increases fluorescence. 
